Ablation Equipments - Medical Devices Pipeline Assessment, 2019

Published : Feb-2019

No. of Pages : 107

order by fax Inquire before Buying request discount

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Ablation Equipments Overview
3 Products under Development
3.1 Ablation Equipments - Pipeline Products by Stage of Development
3.2 Ablation Equipments - Pipeline Products by Territory
3.3 Ablation Equipments - Pipeline Products by Regulatory Path
3.4 Ablation Equipments - Pipeline Products by Estimated Approval Date
3.5 Ablation Equipments - Ongoing Clinical Trials
4 Ablation Equipments - Pipeline Products under Development by Companies
4.1 Ablation Equipments Companies - Pipeline Products by Stage of Development
4.2 Ablation Equipments - Pipeline Products by Stage of Development
5 Ablation Equipments Companies and Product Overview
5.1 AngioDynamics Inc Company Overview
5.2 Avenda Health Inc Company Overview
5.3 CPSI Biotech Company Overview
5.4 Creo Medical Ltd Company Overview
5.5 Deneb Medical SL Company Overview
5.6 Elesta srl Company Overview
5.7 Ethicon US LLC Company Overview
5.8 Eximo Medical Ltd Company Overview
5.9 ExpandoHeat LLC Company Overview
5.10 Fractyl Laboratories Inc Company Overview
5.11 Harmonic Medical Inc Company Overview
5.12 HistoSonics Inc Company Overview
5.13 Hospital for Special Surgery Company Overview
5.14 Imricor Medical Systems Inc Company Overview
5.15 Innoblative Designs, Inc. Company Overview
5.16 Integra LifeSciences Holdings Corp Company Overview
5.17 Intratherm LLC (Inactive) Company Overview
5.18 Massachusetts Institute of Technology Company Overview
5.19 Medtronic plc Company Overview
5.20 Memorial Sloan Kettering Cancer Center Company Overview
5.21 Mirabilis Medical Inc Company Overview
5.22 ProstaCare Pty Ltd Company Overview
5.23 Pulse Biosciences Inc Company Overview
5.24 Sabanci University Nanotechnology Research and Application Center Company Overview
5.25 Southern Illinois University Carbondale Company Overview
5.26 Thermedical Inc Company Overview
5.27 TransEnterix Inc Company Overview
5.28 University of California San Francisco Company Overview
5.29 University of Texas at Austin Company Overview
5.30 University of Wisconsin-Stout Company Overview
6 Ablation Equipments- Recent Developments
6.1 Jul 19, 2018: Olympus names new director of medical and surgical business for the UK and Ireland
6.2 Jul 19, 2018: Misonix appoints Gwen Watanabe as board director
6.3 Jul 11, 2018: AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results
6.4 Jul 10, 2018: Stryker announces organizational changes
6.5 Jul 05, 2018: SonaCare reports long-term results of HIFU therapy for prostate cancer
6.6 Jun 23, 2018: Fractyl Announces Presentation of Key Scientific Research at ADA 2018 Indicating That Modern Diets Durably Alter Duodenal Lining, Highlighting the Intestine's Role in Type 2 Diabetes and NASH
6.7 Jun 14, 2018: HSS Hip and Knee Surgeon Bradford Waddell, MD, Named Chair of Young Arthroplasty Group
6.8 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
6.9 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.10 May 08, 2018: Smith & Nephew: Change of Directorate
6.11 May 07, 2018: New era' for lung cancer patients
6.12 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.13 May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility
6.14 May 07, 2018: Misonix Reports Record Third Quarter Revenue
6.15 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report
6.16 Apr 30, 2018: HSS Surgeon Michael L. Parks, MD, Named President of Orthopaedic Research and Education Foundation
6.17 Apr 26, 2018: AtriCure Reports First Quarter 2018 Financial Results
6.18 Apr 26, 2018: Stryker reports first quarter 2018 operating results
6.19 Apr 25, 2018: KARL STORZ OR1 Operating Rooms - Now Assisting the Surgical Team at Spital Thun, Switzerland
6.20 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.21 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew
6.22 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results
6.23 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth
6.24 Mar 08, 2018: Baylis Medical wins Best Managed Companies award
6.25 Mar 01, 2018: Smith & Nephew: Change in Directorate
6.26 Feb 27, 2018: Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results
6.27 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results
6.28 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Ablation Equipments - Pipeline Products by Stage of Development
Table 2: Ablation Equipments - Pipeline Products by Territory
Table 3: Ablation Equipments - Pipeline Products by Regulatory Path
Table 4: Ablation Equipments - Pipeline Products by Estimated Approval Date
Table 5: Ablation Equipments - Ongoing Clinical Trials
Table 6: Ablation Equipments Companies - Pipeline Products by Stage of Development
Table 7: Ablation Equipments - Pipeline Products by Stage of Development
Table 8: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: NanoKnife 3.0 - Product Status
Table 10: NanoKnife 3.0 - Product Description
Table 11: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Status
Table 12: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Description
Table 13: NanoKnife System - Pancreatic Cancer - Product Status
Table 14: NanoKnife System - Pancreatic Cancer - Product Description
Table 15: NanoKnife System - Prostate Cancer - Product Status
Table 16: NanoKnife System - Prostate Cancer - Product Description
Table 17: AngioDynamics Inc - Ongoing Clinical Trials Overview
Table 18: NanoKnife System - Prostate Cancer - Efficacy and Safety Assessment of Nanoknife (AngyoDynamics, USA) for Irreversible Electroporation (IRE) of Localized Prostate Cancer
Table 19: NanoKnife System - Prostate Cancer - Focal Irreversible Electroporation as Salvage Treatment in Radio-recurrent Prostate Cancer: A Prospective Multicenter Pilot Study
Table 20: NanoKnife System - Prostate Cancer - Irreversible Electroporation (IRE) for Unresectable Prostatic Neoplasms: Phase I and Phase II Clinical Trial
Table 21: NanoKnife System - Prostate Cancer - Multi-center Randomized Clinical Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Localized Prostate Cancer
Table 22: NanoKnife System - Prostate Cancer - Registry of Irreversible Electroporation for the Ablation of Prostate Cancer with Use of Nanoknife Device; A Multi-center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety
Table 23: NanoKnife System - Pancreatic Cancer - A Clinical Research about Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer
Table 24: NanoKnife System - Pancreatic Cancer - A Pilot Study of Irreversible Electroporation for the Treatment of Upfront Resectable Pancreatic Cancer in the Head of the Pancreas
Table 25: NanoKnife System - Pancreatic Cancer - Assessing Optimal Treatment Settings for the Ablation of Locally Advanced Pancreatic Cancer with CT-guided Percutaneous Irreversible Electroporation (ANTILOPE): A Randomized Feasibility Study
Table 26: NanoKnife System - Pancreatic Cancer - Crossatlantic Randomized Controlled Trial Comparing Outcome in Survival after Systemic Plus Focal Therapy for Inoperable Pancreatic Carcinoma: Radiotherapy Versus Irreversible Electroporation: CROSSFIRE Trial
Table 27: NanoKnife System - Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study
Table 28: NanoKnife System - Pancreatic Cancer - Impact of Irreversible Electroporation on Quality of Life for Patients with Locally Advanced Pancreatic Cancer
Table 29: NanoKnife System - Pancreatic Cancer - Interest of Irreversible Electroporation in the Treatment of Pancreatic Adenocarcinoma
Table 30: NanoKnife System - Pancreatic Cancer - IRE: Anti-tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer
Table 31: NanoKnife System - Pancreatic Cancer - Irreversible Electroporation for Locally Advanced Pancreatic Ductal Adenocarcinoma (LEAP TRIAL): A Phase I/II Prospective Trial
Table 32: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation (IRE) for the Treatment of Unresectable Hepatic Carcinoma Close to the Gallbladder
Table 33: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers
Table 34: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Colorectal Metastatic Liver Disease: Efficacy of Irreversible Electroporation (IRE) - A Phase II Clinical Trial: COLDFIRE-2 Study
Table 35: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer
Table 36: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Comparison Percutaneous Cryosurgery and Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
Table 37: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Hepatic Carcinoma in Poor Liver Function: Safety and Efficacy of Irreversible Electroporation (IRE)
Table 38: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Irreversible Electroporation (IRE) for Unresectable Portal Venous Tumor Emboli: Phase I and Phase II Clinical Trial
Table 39: NanoKnife 3.0 - The Safety and Feasibility of Irreversible Electroporation for the Ablation of Small Renal Masses
Table 40: Avenda Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Fiber - Optic Laser - Product Status
Table 42: Fiber - Optic Laser - Product Description
Table 43: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Pressurized Sub-Cooled Nitrogen System - Product Status
Table 45: Pressurized Sub-Cooled Nitrogen System - Product Description
Table 46: Super-Critical Nitrogen (SCN) Cryoablation Platform - Product Status
Table 47: Super-Critical Nitrogen (SCN) Cryoablation Platform - Product Description
Table 48: Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Flexible Ablation System - Product Status
Table 50: Flexible Ablation System - Product Description
Table 51: Deneb Medical SL Pipeline Products & Ongoing Clinical Trials Overview
Table 52: BoneCut Collaborative Robot - Product Status
Table 53: BoneCut Collaborative Robot - Product Description
Table 54: Elesta srl Pipeline Products & Ongoing Clinical Trials Overview
Table 55: EchoLaser - Product Status
Table 56: EchoLaser - Product Description
Table 57: EchoLaser EVO SoracteLite - Product Status
Table 58: EchoLaser EVO SoracteLite - Product Description
Table 59: Elesta srl - Ongoing Clinical Trials Overview
Table 60: EchoLaser - Transperineal Laser Ablation for Treatment of LUTS due to Benign Prostatic Obstruction
Table 61: Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Next Generation Ablation Catheter - Product Status
Table 63: Next Generation Ablation Catheter - Product Description
Table 64: Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 65: B-Laser - Gastrointestinal Procedures - Product Status
Table 66: B-Laser - Gastrointestinal Procedures - Product Description
Table 67: ExpandoHeat LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Catheter Device - Tissue Ablation - Product Status
Table 69: Catheter Device - Tissue Ablation - Product Description
Table 70: Fractyl Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Revita DMR System - Product Status
Table 72: Revita DMR System - Product Description
Table 73: Fractyl Laboratories Inc - Ongoing Clinical Trials Overview
Table 74: Revita DMR System - Evaluation of Duodenal Mucosal Resurfacing (DMR) for the Treatment of Non Alcoholic Steatohepatitis (NASH), a Proof of Concept Study
Table 75: Revita DMR System - Evaluation of Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes
Table 76: Revita DMR System - Evaluation of the Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)
Table 77: Revita DMR System - Evaluation of the Fractyl Duodenal Remodeling System for the Treatment of Type 2 Diabetes
Table 78: Revita DMR System - Multicenter Clinical Trial of Revita DMR Procedure in Patients with Diabetes
Table 79: Revita DMR System - Randomized, Double-blind, Sham-controlled, Prospective, Multi-center Pilot Study to Evaluate the Safety and Effectiveness of Duodenal Mucosal Resurfacing Using the Revita System in the Treatment of Type 2 Diabetes
Table 80: Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - Product Status
Table 82: Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - Product Description
Table 83: Harmonic Medical Inc - Ongoing Clinical Trials Overview
Table 84: Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - MRI-guided High Intensity Focused Ultrasound Ablation of Leiomyomas. Single Arm, Feasibility Study Using the Symphony - MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas.
Table 85: HistoSonics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Vortx RX - Product Status
Table 87: Vortx RX - Product Description
Table 88: Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Radiofrequency Ablation Device - Product Status
Table 90: Radiofrequency Ablation Device - Product Description
Table 91: Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Vision MR Ablation Catheter - Product Status
Table 93: Vision MR Ablation Catheter - Product Description
Table 94: Imricor Medical Systems Inc - Ongoing Clinical Trials Overview
Table 95: Vision MR Ablation Catheter - Cardiovascular Magnetic Resonance-guided Radiofrequency-ablation for Atrial Flutter
Table 96: Innoblative Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview

1.2 List of Figures
Figure 1: Ablation Equipments - Pipeline Products by Stage of Development
Figure 2: Ablation Equipments - Pipeline Products by Territory
Figure 3: Ablation Equipments - Pipeline Products by Regulatory Path
Figure 4: Ablation Equipments - Pipeline Products by Estimated Approval Date
Figure 5: Ablation Equipments - Ongoing Clinical Trials

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Ablation Equipments - Medical Devices Pipeline Assessment, 2019

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027